A.P. Moeller-Maersk A/S Series A (0O76)
London Exchange · UK · prices in DKK · close of 19 Oct 2026
Key indicators
| Last close | DKK 23,750.00 |
|---|---|
| 52-week range | 11,799.34 – 24,050.00 |
| Return, 1 month / 3 months | +8.6% / +44.8% |
| Return, 1 year / 3 years | +98.1% / +64.2% |
| Trend | Uptrend |
| RSI (14) | 61 |
| Volatility (1 year) | 39.6% |
| Worst drawdown (1 year) | -20.2% |
| Average daily value traded | 0.59M DKK |
| Dividend yield | 2.0% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
A.P. Moeller-Maersk A/S is a Danish transport and logistics group based in Copenhagen. Its main activity is container shipping, moving goods across the world's sea routes for manufacturers, retailers and other businesses that trade internationally. The company also runs port terminals and offers supply chain services such as freight forwarding and inland transport, helping customers move cargo from door to door. Its customers include exporters, importers and companies that depend on global trade.
The shares are listed on the London Exchange in UK under the code 0O76, and the price on this page is in Danish kroner (DKK). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
A.P. Moeller-Maersk A/S Series A (0O76) trades on the London Exchange in UK. It last closed at DKK 23,750.00 on 19 October 2026.
Its price-based Market X-Ray is 72 out of 100 (a strong price profile), ranking 409 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 98.1% and over the last three months it rose 44.8%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 95 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 41.4% | ||
| From 52-week high | -1.0% | ||
| Momentum | 95 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 44.8% | ||
| 6-month return | 51.7% | ||
| 12-month return, skipping the last month | – | ||
| Risk (lower is better) | 57 · Fair | Typical risk for this exchange. | |
| Volatility (1 year) | 39.6% | ||
| Worst drawdown (1 year) | -20.2% | ||
| Liquidity | 33 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.59M DKK | ||
| Zero-volume days | 38.3% | ||
| Income | 50 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 2.0% | ||
| Years with dividends | 5 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
Weak spots
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | −1.0% |
|---|---|
| 1 month | +8.6% |
| 3 months | +44.8% |
| 6 months | +51.7% |
| 1 year | +98.1% |
| 3 years | +64.2% |
| 5 years | – |
Signals
| 50-day / 200-day average | 21,635.90 / 16,792.85 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 674.78 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 26 Mar 2026 | DKK 480.0000 |
| 19 Mar 2025 | DKK 1,120.0000 |
| 15 Mar 2024 | DKK 495.1350 |
| 29 Mar 2023 | DKK 2,211.2825 |
| 16 Mar 2022 | DKK 2,403.5680 |
| 24 Mar 2021 | DKK 317.2710 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.